
Shares in French biotech company Abivax ABVX.PA up as much as 19% with two traders citing market speculation about potential takeover interest from Eli Lilly LLY.N
Abivax and Eli Lilly were not immediately available for comment
If gains hold, Abivax will add 1.5 billion euros to its market value of 7.8 billion euros ($9.1 billion)
($1 = 0.8592 euros)